- Copper-Catalyzed Hydroxylation of (Hetero)aryl Halides under Mild Conditions
-
The combination of Cu(acac)2 and N,N′-bis(4-hydroxyl-2,6-dimethylphenyl)oxalamide (BHMPO) provides a powerful catalytic system for hydroxylation of (hetero)aryl halides. A wide range of (hetero)aryl chlorides bearing either electron-donating or -withdrawing groups proceeded well at 130 °C, delivering the corresponding phenols and hydroxylated heteroarenes in good to excellent yields. When more reactive (hetero)aryl bromides and iodides were employed, the hydroxylation reactions completed at relatively low temperatures (80 and 60 °C, respectively) at low catalytic loadings (0.5 mol % Cu).
- Xia, Shanghua,Gan, Lu,Wang, Kailiang,Li, Zheng,Ma, Dawei
-
supporting information
p. 13493 - 13496
(2016/10/31)
-
- Sulfonic acid functionalized MCM-41 as solid acid catalyst for tert-butylation of hydroquinone enhanced by microwave heating
-
Covalently linked sulfonic acid (SO3H) modified MCM-41 mesoporous catalysts was prepared, characterized and its catalytic activity under microwave irradiation was evaluated. The NH2-MCM-41 was first prepared by anchoring (3-aminoprop
- Ng, Eng-Poh,Mohd Subari, Siti Norbayu,Marie, Olivier,Mukti, Rino R.,Juan, Joon-Ching
-
-
- Angiotensin II antagonists
-
This invention provides novel heterocyclic derivatives, their pharmaceutical formulations, and their use for antagonizing angiotensin II receptors in mammals.
- -
-
-
- Angiotensin II antagonist intermediates
-
This invention provides novel heterocyclic derivatives, their pharmaceutical formulations, and their use for antagonizing angiotensin II receptors in mammals.
- -
-
-
- Angiotensin II antagonists
-
This invention provides novel phenyl and heterocyclic derivatives, their pharmaceutical formulations and their methods of use for antagonizing angiotensin II receptors in mammals.
- -
-
-